Stay updated on CPX-351 and Quizartinib in AML Clinical Trial
Sign up to get notified when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.

Latest updates to the CPX-351 and Quizartinib in AML Clinical Trial page
- Check5 days agoChange DetectedAdded Revision: v3.4.3; Deleted Revision: v3.4.2.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new version entry was added to the Record History, reflecting updated study status and recent changes to the record.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded Revision: v3.4.2 to the record history; removed the government-funding/operating-status notice and the previous Revision: v3.4.1 entry.SummaryDifference0.7%

- Check40 days agoChange DetectedAdded a government funding/operating-status notice and updated the site release to Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.7%

- Check48 days agoChange DetectedThe Record History page UI includes a glossary toggle and color-coded explanations for additions and deletions, plus updated revision notes (e.g., Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check62 days agoChange DetectedA new revision entry (v3.3.4) was added and an earlier revision (v3.3.3) removed in the study record history; this is a minor/versioning update with no impact on trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to CPX-351 and Quizartinib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.